Strand V - Search Results

1

Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents.

Strand V, Gonçalves J, Hickling TP, Jones HE, Marshall L, Isaacs JD. Strand V, et al. BioDrugs. 2020 Apr;34(2):253. doi: 10.1007/s40259-020-00410-5. BioDrugs. 2020. PMID: 32103456 Free PMC article.

2

Combination biologic therapy.

Isaacs JD, Morgan AW, Strand V. Isaacs JD, et al. Among authors: strand v. Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S121-4. Clin Exp Rheumatol. 1999. PMID: 10589370 Review.

3

Biologic therapies in rheumatology: lessons learned, future directions.

Strand V, Kimberly R, Isaacs JD. Strand V, et al. Nat Rev Drug Discov. 2007 Jan;6(1):75-92. doi: 10.1038/nrd2196. Nat Rev Drug Discov. 2007. PMID: 17195034 Review.

4

The role of biosimilars in the treatment of rheumatic diseases.

Dörner T, Strand V, Castañeda-Hernández G, Ferraccioli G, Isaacs JD, Kvien TK, Martin-Mola E, Mittendorf T, Smolen JS, Burmester GR. Dörner T, et al. Among authors: strand v. Ann Rheum Dis. 2013 Mar;72(3):322-8. doi: 10.1136/annrheumdis-2012-202715. Epub 2012 Dec 19. Ann Rheum Dis. 2013. PMID: 23253920 Review.

5

The changing landscape of biosimilars in rheumatology.

Dörner T, Strand V, Cornes P, Gonçalves J, Gulácsi L, Kay J, Kvien TK, Smolen J, Tanaka Y, Burmester GR. Dörner T, et al. Among authors: strand v. Ann Rheum Dis. 2016 Jun;75(6):974-82. doi: 10.1136/annrheumdis-2016-209166. Epub 2016 Mar 8. Ann Rheum Dis. 2016. PMID: 26964144 Free PMC article. Review.

6

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.

Clowse ME, Feldman SR, Isaacs JD, Kimball AB, Strand V, Warren RB, Xibillé D, Chen Y, Frazier D, Geier J, Proulx J, Marren A. Clowse ME, et al. Among authors: strand v. Drug Saf. 2016 Aug;39(8):755-62. doi: 10.1007/s40264-016-0431-z. Drug Saf. 2016. PMID: 27282428 Free PMC article.

7

Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review.

Strand V, Balsa A, Al-Saleh J, Barile-Fabris L, Horiuchi T, Takeuchi T, Lula S, Hawes C, Kola B, Marshall L. Strand V, et al. BioDrugs. 2017 Aug;31(4):299-316. doi: 10.1007/s40259-017-0231-8. BioDrugs. 2017. PMID: 28612180 Free PMC article. Review.

8

Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents.

Strand V, Gonçalves J, Hickling TP, Jones HE, Marshall L, Isaacs JD. Strand V, et al. BioDrugs. 2020 Feb;34(1):27-37. doi: 10.1007/s40259-019-00394-x. BioDrugs. 2020. PMID: 31721107 Free PMC article. Review.

9

Immunogenicity of biologic agents in rheumatology.

Strand V, Goncalves J, Isaacs JD. Strand V, et al. Nat Rev Rheumatol. 2021 Feb;17(2):81-97. doi: 10.1038/s41584-020-00540-8. Epub 2020 Dec 14. Nat Rev Rheumatol. 2021. PMID: 33318665 Review.

10

Biosimilars: how similar?

Strand V, Cronstein B. Strand V, et al. Intern Med J. 2014 Mar;44(3):218-23. doi: 10.1111/imj.12292. Intern Med J. 2014. PMID: 24118772 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

523 results

Search Page